iShares Evolved U.S. Innovative Healthcare ETF
IEIH
IEIH was delisted on the 22nd of August, 2022.
7 hedge funds and large institutions have $2.71M invested in iShares Evolved U.S. Innovative Healthcare ETF in 2019 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and closing their positions.
40% more funds holding
Funds holding: 5 → 7 (+2)
20% more capital invested
Capital invested by funds: $2.26M → $2.71M (+$449K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$204K |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$26 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$104K |
| 2 |
AG
Advisor Group
Phoenix,
Arizona
|
-$6.5K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
BlackRock
New York
| $1.96M | – | – | – |
|
|
TRCT
2
Tower Research Capital (TRC)
New York
| $430K | -$104K | -3,958 | -20% |
|
|
3
Jane Street
New York
| $217K | +$204K | +7,764 | New |
|
|
AG
4
Advisor Group
Phoenix,
Arizona
| $78K | -$6.5K | -247 | -8% |
|
5
Royal Bank of Canada
Toronto,
Ontario, Canada
| $28K | – | – | – |
|
|
6
Fidelity Investments
Boston,
Massachusetts
| – | +$26 | +1 | New |
|
IEIH Hedge Fund Activity: Q4 2019 in Review
7 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in iShares Evolved U.S. Innovative Healthcare ETF (IEIH) for Q4 2019, worth a combined $2.71M — up 20% from $2.26M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new IEIH positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 2 trimmed.
The largest buyer was Jane Street, opening a new position worth an estimated $204K. The largest seller was Tower Research Capital (TRC), cutting an estimated $104K.
- 7 institutional investors held iShares Evolved U.S. Innovative Healthcare ETF (IEIH) as of Q4 2019, up from 5 in Q3 2019.
- Funds reported $2.71M of iShares Evolved U.S. Innovative Healthcare ETF stock for Q4 2019, up 20% quarter-over-quarter.
- 2 funds opened new iShares Evolved U.S. Innovative Healthcare ETF positions in Q4 2019 and 0 closed out, a net change of +2 holders.
- The largest iShares Evolved U.S. Innovative Healthcare ETF buyer in Q4 2019 was Jane Street, an estimated $204K added.
- The largest iShares Evolved U.S. Innovative Healthcare ETF seller in Q4 2019 was Tower Research Capital (TRC), an estimated $104K sold.
Based on aggregated 13F filings for Q4 2019.